Real-world of Limosilactobacillus reuteri in mitigation of acute experimental colitis
Abstract Probiotics have been proposed as a potential strategy for managing ulcerative colitis (UC). However, the underlying mechanisms mediating microbiota-host crosstalk remain largely elusive. Here, we report that Limosilactobacillus reuteri (L. reuteri), as a probiotic, secretes cytoplasmic memb...
Saved in:
Main Authors: | Ningning Yue, Hailan Zhao, Peng Hu, Yuan Zhang, Chengmei Tian, Chen Kong, Zhiliang Mai, Longbin Huang, Qianjun Luo, Daoru Wei, Ruiyue Shi, Shaohui Tang, Yuqiang Nie, Yujie Liang, Jun Yao, Lisheng Wang, Defeng Li |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | Journal of Nanobiotechnology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12951-025-03158-8 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Limosilactobacillus reuteri - a probiotic gut commensal with contextual impact on immunity
by: Amanda H. Lee, et al.
Published: (2025-12-01) -
Exopolysaccharides from camel milk-derived Limosilactobacillus reuteri C66: Structural characterization, bioactive and rheological properties for food applications
by: A.K.M. Humayun Kober, et al.
Published: (2025-01-01) -
Biological Characteristics Analysis of Limosilactobacillus reuteri JBR3 and the Effect of Protective Agents on Its Viability
by: Jun HAN, et al.
Published: (2025-02-01) -
Clinical Study of Limosilactobacillus reuteri for the Treatment of Children with Chronic Tic Disorders/Tourette Syndrome: A Mid-Term Efficacy Evaluation
by: Yan Liang, et al.
Published: (2024-12-01) -
<i>Limosilactobacillus reuteri</i> ZY15 Alleviates Intestinal Inflammation and Barrier Dysfunction via AKT/mTOR/HIF-1α/RORγt/IL-17 Signaling and the Gut Microbiota in ETEC K88-Challenged <i>Mice</i>
by: Xin Xu, et al.
Published: (2025-01-01)